Regulatory, Tech Transfer & Support Services
Company Overview
About
Docaposte is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:France
Founded:2017
Employees:2,680
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval AFSUC2
Health Canada · #APR-9FPYXU1B · 2019-12-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-82QIQPVF
Issued: 2020-05-12
Expires: 2025-04-12
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-MS2BU5TM
Issued: 2020-01-19
Expires: 2025-11-03
WHO GMP
World Health Organization
Cert #: CERT-YP3GOL8M
Issued: 2020-08-17
Expires: 2025-09-11
Health Canada GMP
Health Canada
Cert #: CERT-UBRDSOR0
Issued: 2020-12-27
Expires: 2025-09-08
Loading CDMO intelligence...
Key facts about Docaposte
- Docaposte is headquartered in France.
- Docaposte was founded in 2017.
- Docaposte has 2,680 employees.
- Docaposte's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Docaposte
Directory pages this company appears in, each with the full list of matching manufacturers.